Fibrocytes: Bringing new insights into mechanisms of inflammation and fibrosis

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 4, 2010, Pages 535-542

  Keeley, Ellen C ^a   Mehrad, Borna ^a   Strieter, Robert M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Fibrocyte; Fibrosis

Indexed keywords

CHEMOKINE RECEPTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOKINE; FIBRONECTIN; GROWTH FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIMENTIN;

ARTERY INTIMA PROLIFERATION; ASTHMA; ATHEROSCLEROSIS; CELL DIFFERENTIATION; FIBROSING ALVEOLITIS; FIBROSIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL STROMAL TUMOR; HEMATOPOIETIC STEM CELL; HUMAN; HYPERTROPHIC SCAR; INFLAMMATORY DISEASE; ISCHEMIC HEART DISEASE; KELOID; LYME DISEASE; MESENCHYMAL STEM CELL; MITRAL VALVE DISEASE; NEPHROGENIC SYSTEMIC FIBROSIS; NONHUMAN; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; REVIEW; SCLERODERMA; TISSUE REGENERATION; URINARY TRACT DISEASE; VITREORETINOPATHY; WOUND HEALING;

ANIMALS; ANTIGENS, CD34; BONE MARROW; CELL DIFFERENTIATION; FIBROSIS; HUMANS; INFLAMMATION; MESENCHYMAL STEM CELLS; REGENERATION; WOUND HEALING;

EID: 77649189292     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.10.014     Document Type: Review

References (96)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304.
2. Abe R., Donnelly S.C., Peng T., Bucala R., and Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166 (2001) 7556-7562
3. Abu El-Asrar A.M., Struyf S., Van Damme J., and Geboes K. Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Br J Ophthalmol 92 (2008) 699-704
4. Aiba S., Tabata N., Ohtani H., and Tagami H. CD34+ spindle-shaped cells selectively disappear from the skin lesion of scleroderma. Arch Dermatol 130 (1994) 593-597
5. Aiba S., and Tagami H. Inverse correlation between CD34 expression and proline-4-hydroxylase immunoreactivity on spindle cells noted in hypertrophic scars and keloids. J Cutan Pathol 24 (1997) 65-69
6. Andersson-Sjoland A., de Alba C.G., Nihlberg K., Becerril C., Ramirez R., Pardo A., et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 40 (2008) 2129-2140
7. Barth P.J., Ebrahimsade S., Hellinger A., Moll R., and Ramaswamy A. CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch 440 (2002) 128-133
8. Barth P.J., Ebrahimsade S., Ramaswamy A., and Moll R. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Arch 440 (2002) 298-303
9. Barth P.J., Koster H., and Moosdorf R. CD34+ fibrocytes in normal mitral valves and myxomatous mitral valve degeneration. Pathol Res Pract 201 (2005) 301-304
10. Barth P.J., Ramaswamy A., and Moll R. CD34(+) fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri. Virchows Arch 441 (2002) 564-568
11. Barth P.J., Schenck zu Schweinsberg T., Ramaswamy A., and Moll R. CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Virchows Arch 444 (2004) 231-234
12. Barth P.J., and Westhoff C.C. CD34+ fibrocytes: morphology, histogenesis and function. Curr Stem Cell Res Ther 2 (2007) 221-227
13. Bellini A., and Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 87 (2007) 858-870
14. Bucala R. Circulating fibrocytes: cellular basis for NSF. J Am Coll Radiol 5 (2008) 36-39
15. Bucala R., Spiegel L.A., Chesney J., Hogan M., and Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1 (1994) 71-81
16. 2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma. Arthritis Rheum 54 (2006) 2632-2642
17. Chesney J., Bacher M., Bender A., and Bucala R. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A 94 (1997) 6307-6312
18. Chesney J., Metz C., Stavitsky A.B., Bacher M., and Bucala R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 160 (1998) 419-425
19. Cowper S.E., and Bucala R. Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am J Dermatopathol 25 (2003) 358
20. Cowper S.E., Rabach M., and Girardi M. Clinical and histological findings in nephrogenic systemic fibrosis. Eur J Radiol 66 (2008) 191-199
21. Davies D.E., Wicks J., Powell R.M., Puddicombe S.M., and Holgate S.T. Airway remodeling in asthma: new insights. J Allergy Clin Immunol 111 (2003) 215-225 [quiz 226]
22. Dewald O., Frangogiannis N.G., Zoerlein M., Duerr G.D., Klemm C., Knuefermann P., et al. Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species. Proc Natl Acad Sci U S A 100 (2003) 2700-2705
23. Dewald O., Zymek P., Winkelmann K., Koerting A., Ren G., Abou-Khamis T., et al. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 96 (2005) 881-889
24. Ebihara Y., Masuya M., Larue A.C., Fleming P.A., Visconti R.P., Minamiguchi H., et al. Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. Exp Hematol 34 (2006) 219-229
25. Ebrahimsade S., Westhoff C.C., and Barth P.J. CD34+ fibrocytes are preserved in most invasive lobular carcinomas of the breast. Pathol Res Pract 203 (2007) 695-698
26. Ehrlich H.P., Desmouliere A., Diegelmann R.F., Cohen I.K., Compton C.C., Garner W.L., et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145 (1994) 105-113
27. Epperly M.W., Guo H., Gretton J.E., and Greenberger J.S. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol 29 (2003) 213-224
28. Farber H.W., and Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 351 (2004) 1655-1665
29. Frid M.G., Brunetti J.A., Burke D.L., Carpenter T.C., Davie N.J., Reeves J.T., et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 168 (2006) 659-669
30. Galan A., Cowper S.E., and Bucala R. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Curr Opin Rheumatol 18 (2006) 614-617
31. Gizycki M.J., Adelroth E., Rogers A.V., O'Byrne P.M., and Jeffery P.K. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol 16 (1997) 664-673
32. Gomperts B.N., and Strieter R.M. Fibrocytes in lung disease. J Leukoc Biol 82 (2007) 449-456
33. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5 (2005) 953-964
34. Grab D.J., Lanners H., Martin L.N., Chesney J., Cai C., Adkisson H.D., et al. Interaction of Borrelia burgdorferi with peripheral blood fibrocytes, antigen-presenting cells with the potential for connective tissue targeting. Mol Med 5 (1999) 46-54
35. Grab D.J., Salim M., Chesney J., Bucala R., and Lanners H.N. A role for peripheral blood fibrocytes in Lyme disease?. Med Hypotheses 59 (2002) 1-10
36. Hartlapp I., Abe R., Saeed R.W., Peng T., Voelter W., Bucala R., et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 15 (2001) 2215-2224
37. Hashimoto N., Jin H., Liu T., Chensue S.W., and Phan S.H. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 113 (2004) 243-252
38. Haudek S.B., Xia Y., Huebener P., Lee J.M., Carlson S., Crawford J.R., et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci U S A 103 (2006) 18284-18289
39. Hayashida K., Fujita J., Miyake Y., Kawada H., Ando K., Ogawa S., et al. Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension. Chest 127 (2005) 1793-1798
40. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., and Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110 (2002) 341-350
41. Kalluri R., and Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112 (2003) 1776-1784
42. 2A receptor blockade or deletion diminishes fibrocyte accumulation in the skin in a murine model of scleroderma, bleomycin-induced fibrosis. Inflammation 31 (2008) 299-303
43. Kaur D., Saunders R., Berger P., Siddiqui S., Woodman L., Wardlaw A., et al. Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. Am J Respir Crit Care Med 174 (2006) 1179-1188
44. Keeley E.C., Mehrad B., and Strieter R.M. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders. Thromb Haemost 101 (2009) 613-618
45. Kisseleva T., and Brenner D.A. Fibrogenesis of parenchymal organs. Proc Am Thorac Soc 5 (2008) 338-342
46. Kisseleva T., and Brenner D.A. Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 233 (2008) 109-122
47. Kisseleva T., Uchinami H., Feirt N., Quintana-Bustamante O., Segovia J.C., Schwabe R.F., et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45 (2006) 429-438
48. Kojc N., Zidar N., Vodopivec B., and Gale N. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx. Hum Pathol 36 (2005) 16-21
49. Kuroda N., Guo L., Miyazaki E., Hamauzu T., Toi M., Hiroi M., et al. The appearance of myofibroblasts and the disappearance of CD34-positive stromal cells in the area adjacent to xanthogranulomatous foci of chronic cholecystitis. Histol Histopathol 20 (2005) 127-133
50. Kuroda N., Shimasaki N., Miyazaki E., Hamauzu T., Toi M., Hiroi M., et al. The distribution of myofibroblasts and CD34-positive stromal cells in normal renal pelvis and ureter and their cancers. Histol Histopathol 21 (2006) 1303-1307
51. Kuroda N., Toi M., Nakayama H., Miyazaki E., Yamamoto M., Hayashi Y., et al. The distribution and role of myofibroblasts and CD34-positive stromal cells in normal pancreas and various pancreatic lesions. Histol Histopathol 19 (2004) 59-67
52. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger Jr. T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15 (1988) 202-205
53. Marckmann P., Skov L., Rossen K., and Thomsen H.S. Clinical manifestation of gadodiamide-related nephrogenic systemic fibrosis. Clin Nephrol 69 (2008) 161-168
54. McLaughlin V.V., Archer S.L., Badesch D.B., Barst R.J., Farber H.W., Lindner J.R., et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 53 (2009) 1573-1619
55. Medbury H.J., Tarran S.L., Guiffre A.K., Williams M.M., Lam T.H., Vicaretti M., et al. Monocytes contribute to the atherosclerotic cap by transformation into fibrocytes. Int Angiol 27 (2008) 114-123
56. Mehrad B., Burdick M.D., and Strieter R.M. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. Int J Biochem Cell Biol 41 (2009) 1708-1718
57. Mehrad B., Burdick M.D., Zisman D.A., Keane M.P., Belperio J.A., and Strieter R.M. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 353 (2007) 104-108
58. Mendoza F.A., Artlett C.M., Sandorfi N., Latinis K., Piera-Velazquez S., and Jimenez S.A. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 35 (2006) 238-249
59. Metz C.N. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 60 (2003) 1342-1350
60. Moeller A., Gilpin S.E., Ask K., Cox G., Cook D., Gauldie J., et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179 (2009) 588-594
61. Mold C., Baca R., and Du Clos T.W. Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcgamma receptors. J Autoimmun 19 (2002) 147-154
62. Moore B.B., Kolodsick J.E., Thannickal V.J., Cooke K., Moore T.A., Hogaboam C., et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166 (2005) 675-684
63. Moore B.B., Murray L., Das A., Wilke C.A., Herrygers A.B., and Toews G.B. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol 35 (2006) 175-181
64. Morcos S.K., and Thomsen H.S. Nephrogenic systemic fibrosis: more questions and some answers. Nephron Clin Pract 110 (2008) c24-c31 [discussion c32]
65. Mori L., Bellini A., Stacey M.A., Schmidt M., and Mattoli S. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 304 (2005) 81-90
66. Murdoch C. CXCR4: chemokine receptor extraordinaire. Immunol Rev 177 (2000) 175-184
67. Nath K.A. The tubulointerstitium in progressive renal disease. Kidney Int 54 (1998) 992-994
68. Nihlberg K., Larsen K., Hultgardh-Nilsson A., Malmstrom A., Bjermer L., and Westergren-Thorsson G. Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane?. Respir Res 7 (2006) 50
69. Nimphius W., Moll R., Olbert P., Ramaswamy A., and Barth P.J. CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder. Virchows Arch 450 (2007) 179-185
70. Okon K., Szumera A., and Kuzniewski M. Are CD34+ cells found in renal interstitial fibrosis?. Am J Nephrol 23 (2003) 409-414
71. Ortiz L.A., Gambelli F., McBride C., Gaupp D., Baddoo M., Kaminski N., et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 100 (2003) 8407-8411
72. Phillips R.J., Burdick M.D., Hong K., Lutz M.A., Murray L.A., Xue Y.Y., et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114 (2004) 438-446
73. Pilling D., Buckley C.D., Salmon M., and Gomer R.H. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 171 (2003) 5537-5546
74. Pilling D., Tucker N.M., and Gomer R.H. Aggregated IgG inhibits the differentiation of human fibrocytes. J Leukoc Biol 79 (2006) 1242-1251
75. Quan T.E., Cowper S., Wu S.P., Bockenstedt L.K., and Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36 (2004) 598-606
76. Rabkin E., Aikawa M., Stone J.R., Fukumoto Y., Libby P., and Schoen F.J. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104 (2001) 2525-2532
77. Ramaswamy A., Moll R., and Barth P.J. CD34+ fibrocytes in tubular carcinomas and radial scars of the breast. Virchows Arch 443 (2003) 536-540
78. Rojas M., Xu J., Woods C.R., Mora A.L., Spears W., Roman J., et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33 (2005) 145-152
79. Ruiz-Ortega M., Ruperez M., Esteban V., Rodriguez-Vita J., Sanchez-Lopez E., Carvajal G., et al. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21 (2006) 16-20
80. Russo R., Medbury H., Guiffre A., Englert H., and Manolios N. Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma. Clin Rheumatol 26 (2007) 1136-1141
81. Sakai N., Wada T., Matsushima K., Bucala R., Iwai M., Horiuchi M., et al. The renin-angiotensin system contributes to renal fibrosis through regulation of fibrocytes. J Hypertens 26 (2008) 780-790
82. Sakai N., Wada T., Yokoyama H., Lipp M., Ueha S., Matsushima K., et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 103 (2006) 14098-14103
83. Sakai Y., and Matsukuma S. CD34+ stromal cells and hyalinized vascular changes in the anal fibroepithelial polyps. Histopathology 41 (2002) 230-235
84. Saunders R., Siddiqui S., Kaur D., Doe C., Sutcliffe A., Hollins F., et al. Fibrocyte localization to the airway smooth muscle is a feature of asthma. J Allergy Clin Immunol 123 (2009) 376-384
85. Schmidt M., Sun G., Stacey M.A., Mori L., and Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 171 (2003) 380-389
86. Shao D.D., Suresh R., Vakil V., Gomer R.H., and Pilling D. Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 83 (2008) 1323-1333
87. Tacke F., and Randolph G.J. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211 (2006) 609-618
88. Uehara H., Nakagawa T., Katsuno T., Sato T., Isono A., Noguchi Y., et al. Emergence of fibrocytes showing morphological changes in the inflamed colonic mucosa. Dig Dis Sci (2009) 10.1007/s10620-009-0730-7
89. Varcoe R.L., Mikhail M., Guiffre A.K., Pennings G., Vicaretti M., Hawthorne W.J., et al. The role of the fibrocyte in intimal hyperplasia. J Thromb Haemost 4 (2006) 1125-1133
90. Wang C.H., Huang C.D., Lin H.C., Lee K.Y., Lin S.M., Liu C.Y., et al. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am J Respir Crit Care Med 178 (2008) 583-591
91. Wang J.F., Jiao H., Stewart T.L., Shankowsky H.A., Scott P.G., and Tredget E.E. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen 15 (2007) 113-121
92. Wessel C., Westhoff C.C., Nowak K., Moll I., and Barth P.J. CD34(+) fibrocytes in melanocytic nevi and malignant melanomas of the skin. Virchows Arch 453 (2008) 485-489
93. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J Pathol 214 (2008) 199-210
94. Yang L., Scott P.G., Dodd C., Medina A., Jiao H., Shankowsky H.A., et al. Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 13 (2005) 398-404
95. Yang L., Scott P.G., Giuffre J., Shankowsky H.A., Ghahary A., and Tredget E.E. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 82 (2002) 1183-1192
96. Zulli A., Buxton B.F., Black M.J., and Hare D.L. CD34 Class III positive cells are present in atherosclerotic plaques of the rabbit model of atherosclerosis. Histochem Cell Biol 124 (2005) 517-522